Biological evaluation of compounds for their physical dependence potential and abuse liability. XIII. Drug Testing Program of the Committee on Problems of Drug Dependence, Inc.
Jacobson
A E
AE
Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004353:Drug Evaluation, Preclinical / Q000379:methods; D013287:Illicit Drugs; D051379:Mice; D009294:Narcotics; D009293:Opioid-Related Disorders / Q000209:etiology; D011619:Psychotropic Drugs; D013329:Structure-Activity Relationship; D019966:Substance-Related Disorders / Q000209:etiology*
D013287:Illicit Drugs; D009294:Narcotics; D011619:Psychotropic Drugs